Cargando…
Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554321/ https://www.ncbi.nlm.nih.gov/pubmed/36247069 http://dx.doi.org/10.1016/j.medcle.2022.10.002 |
_version_ | 1784806667959926784 |
---|---|
author | Sopena, Eugenia Canadell, Laura Qanneta, Rami |
author_facet | Sopena, Eugenia Canadell, Laura Qanneta, Rami |
author_sort | Sopena, Eugenia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9554321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95543212022-10-12 Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection Sopena, Eugenia Canadell, Laura Qanneta, Rami Med Clin (Engl Ed) Scientific Letter Elsevier España, S.L.U. 2022-11-11 2022-10-12 /pmc/articles/PMC9554321/ /pubmed/36247069 http://dx.doi.org/10.1016/j.medcle.2022.10.002 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Scientific Letter Sopena, Eugenia Canadell, Laura Qanneta, Rami Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection |
title | Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection |
title_full | Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection |
title_fullStr | Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection |
title_full_unstemmed | Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection |
title_short | Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection |
title_sort | bismuth subcitrate as treatment of diarrhea in fragile patients with sars-cov-2 infection |
topic | Scientific Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554321/ https://www.ncbi.nlm.nih.gov/pubmed/36247069 http://dx.doi.org/10.1016/j.medcle.2022.10.002 |
work_keys_str_mv | AT sopenaeugenia bismuthsubcitrateastreatmentofdiarrheainfragilepatientswithsarscov2infection AT canadelllaura bismuthsubcitrateastreatmentofdiarrheainfragilepatientswithsarscov2infection AT qannetarami bismuthsubcitrateastreatmentofdiarrheainfragilepatientswithsarscov2infection |